NCT05551169 is a clinical trial in COPD, sponsored by Peking University First Hospital.

Who is sponsoring NCT05551169?

NCT05551169 is sponsored by Peking University First Hospital.

Is NCT05551169 still recruiting?

NCT05551169 is currently completed. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT05551169

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Detect and Infer the Severity of COPD by Intelligent Terminal Device

Completed Last updated 5 January 2024

What this trial tests

trial in COPD in 432 participants. Completed in 11 August 2023.

Timeline

21 June 2022

Primary endpoint
11 August 2023

11 August 2023

Quick facts

Lead sponsor	Peking University First Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	432
Start date	21 June 2022
Primary completion	11 August 2023
Estimated completion	11 August 2023
Sites	10 locations across China

Conditions studied

COPD — all drugs for COPD →

Sponsor

Peking University First Hospital

Who can join

18 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, investigators aim to develop an algorithm that can detect and infer the severity level of COPD from physiological parameters and audio data which are collected by a wearable device. Investigators will complete the study in two stages: stage 1. A panel study to assess the ability to infer the severity of COPD by intelligent terminal devices; stage 2. Establish an algorithm that can detect and infer the severity level of COPD by intelligent terminal devices.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Intelligent wearable devices with audio collection capabilities to assess chronic obstructive pulmonary disease severity.
Zhang C, Yu K, Jin Z, Bao Y, et al · · 2025 · cited 3× · PMID 40093702 · DOI 10.1177/20552076251320730
The value of cough sound monitoring via an audio-enabled smartwatch for OSA screening in COPD patients: a cross-sectional exploratory study.
Zhang C, Zhang C, Jin Z, Yu K, et al · · 2025 · PMID 41133160 · DOI 10.3389/fmed.2025.1650014

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Peking University First Hospital trials

Trials by the same sponsor.

NCT07498907 — Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelia · Phase 2 · not yet recruiting
NCT07517276 — TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index · Phase 2 · not yet recruiting
NCT07504939 — Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma · not yet recruiting
NCT07464119 — A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy · NA · not yet recruiting
NCT07460843 — Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05551169 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University First Hospital
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05551169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing